Sandra Alonso‐Gil

1.4k total citations
25 papers, 1.1k citations indexed

About

Sandra Alonso‐Gil is a scholar working on Molecular Biology, Pharmacology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Sandra Alonso‐Gil has authored 25 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 9 papers in Pharmacology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Sandra Alonso‐Gil's work include Phosphodiesterase function and regulation (10 papers), Cholinesterase and Neurodegenerative Diseases (9 papers) and Nuclear Receptors and Signaling (5 papers). Sandra Alonso‐Gil is often cited by papers focused on Phosphodiesterase function and regulation (10 papers), Cholinesterase and Neurodegenerative Diseases (9 papers) and Nuclear Receptors and Signaling (5 papers). Sandra Alonso‐Gil collaborates with scholars based in Spain, United States and France. Sandra Alonso‐Gil's co-authors include Ana Pérez‐Castillo, José Á. Morales-García, Carmen Gil, Ana Martı́nez, Ángel Santos, Marina Sanz-SanCristóbal, Concepción Pérez, Valle Palomo, Marı́a Isabel Rodrı́guez-Franco and Jordi Riba and has published in prestigious journals such as PLoS ONE, Journal of Molecular Biology and Scientific Reports.

In The Last Decade

Sandra Alonso‐Gil

24 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sandra Alonso‐Gil Spain 18 572 359 289 211 172 25 1.1k
José Á. Morales-García Spain 28 940 1.6× 556 1.5× 431 1.5× 340 1.6× 205 1.2× 56 2.0k
Carmen Navarrete Spain 21 322 0.6× 720 2.0× 293 1.0× 115 0.5× 28 0.2× 33 1.2k
Norberto Aguirre Spain 25 666 1.2× 385 1.1× 759 2.6× 52 0.2× 265 1.5× 47 1.7k
Karen Benwell United Kingdom 13 401 0.7× 180 0.5× 493 1.7× 120 0.6× 101 0.6× 16 909
Laura Rauser United States 10 552 1.0× 226 0.6× 433 1.5× 161 0.8× 82 0.5× 11 1.4k
Oscar Sasso Italy 22 492 0.9× 943 2.6× 382 1.3× 67 0.3× 33 0.2× 27 1.7k
María Gómez‐Cañas Spain 18 277 0.5× 801 2.2× 367 1.3× 85 0.4× 25 0.1× 33 1.1k
David Pubill Spain 28 754 1.3× 323 0.9× 1.4k 4.9× 48 0.2× 608 3.5× 85 2.2k
Agnès Rioux Bilan France 17 582 1.0× 130 0.4× 365 1.3× 29 0.1× 35 0.2× 24 1.3k
Jordi Camarasa Spain 17 329 0.6× 115 0.3× 464 1.6× 24 0.1× 110 0.6× 31 760

Countries citing papers authored by Sandra Alonso‐Gil

Since Specialization
Citations

This map shows the geographic impact of Sandra Alonso‐Gil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Alonso‐Gil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Alonso‐Gil more than expected).

Fields of papers citing papers by Sandra Alonso‐Gil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Alonso‐Gil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Alonso‐Gil. The network helps show where Sandra Alonso‐Gil may publish in the future.

Co-authorship network of co-authors of Sandra Alonso‐Gil

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Alonso‐Gil. A scholar is included among the top collaborators of Sandra Alonso‐Gil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Alonso‐Gil. Sandra Alonso‐Gil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zapata‐Muñoz, Juan, Juan Ignacio Jiménez‐Loygorri, Michael Stumpe, et al.. (2025). The Developing Retina Undergoes Mitochondrial Remodeling via PINK1/PRKN-dependent Mitophagy. Journal of Molecular Biology. 437(18). 169263–169263.
2.
Bartolomé, Fernando Benito, Elena Giné, Marina Sanz-SanCristóbal, et al.. (2023). C/EBPβ Regulates TFAM Expression, Mitochondrial Function and Autophagy in Cellular Models of Parkinson’s Disease. International Journal of Molecular Sciences. 24(2). 1459–1459. 7 indexed citations
3.
Ramírez‐Pardo, Ignacio, Beatriz Villarejo‐Zori, Juan Ignacio Jiménez‐Loygorri, et al.. (2022). Ambra1haploinsufficiency in CD1 mice results in metabolic alterations and exacerbates age-associated retinal degeneration. Autophagy. 19(3). 784–804. 11 indexed citations
4.
Morales-García, José Á., Marina Sanz-SanCristóbal, Sandra Alonso‐Gil, et al.. (2022). Neuroprotective and Anti-Inflammatory Effects of Linoleic Acid in Models of Parkinson’s Disease: The Implication of Lipid Droplets and Lipophagy. Cells. 11(15). 2297–2297. 55 indexed citations
5.
Morales-García, José Á., Javier Calleja‐Conde, Sandra Alonso‐Gil, et al.. (2020). N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo. Translational Psychiatry. 10(1). 96 indexed citations
6.
Morales-García, José Á., Sandra Alonso‐Gil, Ángel Santos, & Ana Pérez‐Castillo. (2019). Phosphodiesterase 7 Regulation in Cellular and Rodent Models of Parkinson’s Disease. Molecular Neurobiology. 57(2). 806–822. 29 indexed citations
7.
Morales-García, José Á., Elena Giné, Diana Aguilar‐Morante, et al.. (2017). CCAAT/Enhancer binding protein β silencing mitigates glial activation and neurodegeneration in a rat model of Parkinson’s disease. Scientific Reports. 7(1). 13526–13526. 13 indexed citations
8.
Morales-García, José Á., Mario de la Fuente Revenga, Sandra Alonso‐Gil, et al.. (2017). The alkaloids of Banisteriopsis caapi, the plant source of the Amazonian hallucinogen Ayahuasca, stimulate adult neurogenesis in vitro. Scientific Reports. 7(1). 5309–5309. 117 indexed citations
9.
Revenga, Mario de la Fuente, Concepción Pérez, José Á. Morales-García, et al.. (2015). Neurogenic Potential Assessment and Pharmacological Characterization of 6-Methoxy-1,2,3,4-tetrahydro-β-carboline (Pinoline) and Melatonin–Pinoline Hybrids. ACS Chemical Neuroscience. 6(5). 800–810. 25 indexed citations
10.
Revenga, Mario de la Fuente, José Á. Morales-García, Sandra Alonso‐Gil, et al.. (2015). NovelN-Acetyl Bioisosteres of Melatonin: Melatonergic Receptor Pharmacology, Physicochemical Studies, and Phenotypic Assessment of Their Neurogenic Potential. Journal of Medicinal Chemistry. 58(12). 4998–5014. 35 indexed citations
11.
Mestre, Leyre, Miriam Redondo, Francisco J. Carrillo‐Salinas, et al.. (2015). PDE7 inhibitor TC3.6 ameliorates symptomatology in a model of primary progressive multiple sclerosis. British Journal of Pharmacology. 172(17). 4277–4290. 32 indexed citations
12.
Morales-García, José Á., Diana Aguilar‐Morante, Sandra Alonso‐Gil, et al.. (2014). Silencing phosphodiesterase 7B gene by lentiviral-shRNA interference attenuates neurodegeneration and motor deficits in hemiparkinsonian mice. Neurobiology of Aging. 36(2). 1160–1173. 34 indexed citations
13.
Pérez, Concepción, José Á. Morales-García, Sandra Alonso‐Gil, et al.. (2014). New Melatonin–N,N-Dibenzyl(N-methyl)amine Hybrids: Potent Neurogenic Agents with Antioxidant, Cholinergic, and Neuroprotective Properties as Innovative Drugs for Alzheimer’s Disease. Journal of Medicinal Chemistry. 57(9). 3773–3785. 72 indexed citations
14.
Susín, Cristina, José Á. Morales-García, Diana Aguilar‐Morante, et al.. (2012). The new iminothiadiazole derivative VP1.14 ameliorates hippocampal damage after an excitotoxic injury. Journal of Neurochemistry. 122(6). 1193–1202. 16 indexed citations
15.
Morales-García, José Á., Sandra Alonso‐Gil, Marina Sanz-SanCristóbal, et al.. (2012). Glycogen Synthase Kinase 3 Inhibition Promotes Adult Hippocampal Neurogenesis in Vitro and in Vivo. ACS Chemical Neuroscience. 3(11). 963–971. 136 indexed citations
16.
Pérez, Daniel I., Concepción Pérez, José Á. Morales-García, et al.. (2012). Microwave-assisted synthesis of hydroxyphenyl nitrones with protective action against oxidative stress. European Journal of Medicinal Chemistry. 58. 44–49. 17 indexed citations
17.
Redondo, Miriam, José Brea, Daniel I. Pérez, et al.. (2012). Effect of Phosphodiesterase 7 (PDE7) Inhibitors in Experimental Autoimmune Encephalomyelitis Mice. Discovery of a New Chemically Diverse Family of Compounds. Journal of Medicinal Chemistry. 55(7). 3274–3284. 51 indexed citations
18.
Palomo, Valle, Daniel I. Pérez, Concepción Pérez, et al.. (2012). 5-Imino-1,2,4-Thiadiazoles: First Small Molecules As Substrate Competitive Inhibitors of Glycogen Synthase Kinase 3. Journal of Medicinal Chemistry. 55(4). 1645–1661. 74 indexed citations
19.
Morales-García, José Á., Cristina Susín, Sandra Alonso‐Gil, et al.. (2012). Glycogen Synthase Kinase-3 Inhibitors as Potent Therapeutic Agents for the Treatment of Parkinson Disease.. ACS Chemical Neuroscience. 4(2). 350–360. 67 indexed citations
20.
Morales-García, José Á., Miriam Redondo, Sandra Alonso‐Gil, et al.. (2011). Phosphodiesterase 7 Inhibition Preserves Dopaminergic Neurons in Cellular and Rodent Models of Parkinson Disease. PLoS ONE. 6(2). e17240–e17240. 90 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026